ReP USP - Resultado da busca

Artigo de periodico
A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): aconsensus of Latin American experts (2022)
Fay, Fabian F. ; Moreno, Carlos Arturo Alvarez ; Bonvehi, Pablo E. ; Espinoza, Carolina Cucho ; Hidalgo, Marco Luis Herrera ; Lozada, Marcel Marcano ; Perez, Carlos M. ; Pulchinelli Junior, Alvaro ; Flor, Klever Vinicio Sáenz ; Condino Neto, Antonio
Source: International Journal of Infectious Diseases. Unidade: ICB
Subjects: IMUNOLOGIA, COVID-19, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, PACIENTES, ALGORITMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAY, Fabian F. et al. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): aconsensus of Latin American experts. International Journal of Infectious Diseases, v. 117, p. 130-136, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijid.2021.05.011. Acesso em: 12 nov. 2024.
APA
Fay, F. F., Moreno, C. A. A., Bonvehi, P. E., Espinoza, C. C., Hidalgo, M. L. H., Lozada, M. M., et al. (2022). A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): aconsensus of Latin American experts. International Journal of Infectious Diseases, 117, 130-136. doi:10.1016/j.ijid.2021.05.011
NLM
Fay FF, Moreno CAA, Bonvehi PE, Espinoza CC, Hidalgo MLH, Lozada MM, Perez CM, Pulchinelli Junior A, Flor KVS, Condino Neto A. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): aconsensus of Latin American experts [Internet]. International Journal of Infectious Diseases. 2022 ; 117 130-136.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.ijid.2021.05.011
Vancouver
Fay FF, Moreno CAA, Bonvehi PE, Espinoza CC, Hidalgo MLH, Lozada MM, Perez CM, Pulchinelli Junior A, Flor KVS, Condino Neto A. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): aconsensus of Latin American experts [Internet]. International Journal of Infectious Diseases. 2022 ; 117 130-136.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.ijid.2021.05.011
Artigo de periodico
Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance (2021)
Quintas, Carmen Oleaga ; Oliveira Júnior, Edgar Borges de; Rosain, Jérémie ; Rapaport, Franck ; Deswarte, Caroline ; Guérin, Antoine; Sajjath, Sairaj Munavar ; Zhou, Yu Jerry ; Marot, Stéphane; Lozano, Claire ; Branco, Lidia ; Hidalgo, Nuria Fernández ; Lew, Dukhee Betty ; Brunel, Anne Sophiehttps ; Thomas, Caroline; Launay, Elise ; Arias, Andrés Augusto ; Cuffel, Alexis; Monjo, Vanesa Cunill ; Neehus, Anna-Lena ; Marques, Laura; Roynard, Manon; Vélez, Marcela Moncada ; Gerçeker, Bengü; Colobran, Roger ; Vigué, Marie-Gabrielle; Herrera, Gabriela Lopez ; Ruiz, Laura Berron ; Méndez, Nora Hilda Segura ; Romanillos, Patricia O’Farrill ; Voyer, Tom Le; Puel, Anne ; Chantelot, Christine Bellanné ; Ramirez, Kacy A.; Diaz, Lazaro Lorenzo ; Alejo, Noé Ramirez ; Diego, Rebeca Pérez de ; Condino Neto, Antonio ; Mellouli, Fethi ; Gallego, Carlos Rodriguez; Witte, Torsten ; Restrepo, José Franco; Jobim, Mariana ; Dupuis, Stéphanie Boisson ; Jeziorski, Eric ; Fieschi, Claire ; Vogt, Guillaume ; Donadieu, Jean ; Pasquet, Marlène ; Vasconcelos, Julia; Ardeniz, Fatma Omur; Gallo, Mónica Martínez ; Campos, Regis A.; Jobim, Luiz Fernando; Barricarte, Rubén Martínez ; Liu, Kang; Cobat, Aurélie; Abel, Laurent ; Casanova, Jean-Laurent ; Bustamante, Jacinta
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, TUBERCULOSE, INTERLEUCINA 8, POLIMORFISMO, ALELOS, IMUNOGENÉTICA, MUTAÇÃO GENÉTICA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUINTAS, Carmen Oleaga et al. Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance. Journal of Clinical Immunology, p. 19 , 2021Tradução . . Disponível em: https://doi.org/10.1007/s10875-020-00930-3. Acesso em: 12 nov. 2024.
APA
Quintas, C. O., Oliveira Júnior, E. B. de, Rosain, J., Rapaport, F., Deswarte, C., Guérin, A., et al. (2021). Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance. Journal of Clinical Immunology, 19 . doi:10.1007/s10875-020-00930-3
NLM
Quintas CO, Oliveira Júnior EB de, Rosain J, Rapaport F, Deswarte C, Guérin A, Sajjath SM, Zhou YJ, Marot S, Lozano C, Branco L, Hidalgo NF, Lew DB, Brunel AS, Thomas C, Launay E, Arias AA, Cuffel A, Monjo VC, Neehus A-L, Marques L, Roynard M, Vélez MM, Gerçeker B, Colobran R, Vigué M-G, Herrera GL, Ruiz LB, Méndez NHS, Romanillos PO’F, Voyer TL, Puel A, Chantelot CB, Ramirez KA, Diaz LL, Alejo NR, Diego RP de, Condino Neto A, Mellouli F, Gallego CR, Witte T, Restrepo JF, Jobim M, Dupuis SB, Jeziorski E, Fieschi C, Vogt G, Donadieu J, Pasquet M, Vasconcelos J, Ardeniz FO, Gallo MM, Campos RA, Jobim LF, Barricarte RM, Liu K, Cobat A, Abel L, Casanova J-L, Bustamante J. Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance [Internet]. Journal of Clinical Immunology. 2021 ;19 .[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s10875-020-00930-3
Vancouver
Quintas CO, Oliveira Júnior EB de, Rosain J, Rapaport F, Deswarte C, Guérin A, Sajjath SM, Zhou YJ, Marot S, Lozano C, Branco L, Hidalgo NF, Lew DB, Brunel AS, Thomas C, Launay E, Arias AA, Cuffel A, Monjo VC, Neehus A-L, Marques L, Roynard M, Vélez MM, Gerçeker B, Colobran R, Vigué M-G, Herrera GL, Ruiz LB, Méndez NHS, Romanillos PO’F, Voyer TL, Puel A, Chantelot CB, Ramirez KA, Diaz LL, Alejo NR, Diego RP de, Condino Neto A, Mellouli F, Gallego CR, Witte T, Restrepo JF, Jobim M, Dupuis SB, Jeziorski E, Fieschi C, Vogt G, Donadieu J, Pasquet M, Vasconcelos J, Ardeniz FO, Gallo MM, Campos RA, Jobim LF, Barricarte RM, Liu K, Cobat A, Abel L, Casanova J-L, Bustamante J. Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance [Internet]. Journal of Clinical Immunology. 2021 ;19 .[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s10875-020-00930-3
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 12 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases (2016)
Conti, Francesca; Reyes, Saul Oswaldo Lugo; Galicia, Lizbeth Blancas; He, Jianxin; Aksu, Güzide; Oliveira Junior, Edgar Borges de; Deswarte, Caroline; Hubeau, Marjorie; Karaca, Neslihan; Suremain, Maylis de; Guérin, Antoine; Baba, Laia Ait; Prando, Carolina; Guerrero, Gloria G; Emiroglu, Melike; Öz, Fatma Nur; Nakashimada, Marco Antonio Yamazaki; Serrano, Edith Gonzalez; Espinosa, Sara; Barlan, Isil; Pérez, Nestor; Regairaz, Lorena; Morales, Héctor Eduardo Guido; Bezrondnik, Liliana; Giovanni, Daniela Di; Dbaibo, Ghassan; Ailal, Fatima; Galicchio, Miguel; Oleastro, Matias; Chemli, Jalel; Danielian, Silvia; Perez, Laura; Ortega, Maria Claudia; Lavin, Susana Soto; Hertecant, Joseph; Anal, Ozden; Kechout, Nadia; Al-Idrissi, Eman; ElGhazali, Gehad; Bondareko, Anastasia; Chernyshova, Liudmyla; Ciznar, Peter; Herbigneaux, Rose-Marie; Diabate, Aminata; Ndaga, Stéphanie; Konte, Barik; Czarna, Ambre; Migaud, Mélanie; Sánchez, Sigifredo Pedraza; Zaidi, Mussaret Bano; Vogt, Guillaume; Blanche, Stéphane; Benmustapha, Imen; Mansouri, Davood; Abel, Laurent; Dupuis, Stéphanie Boisson; Mahlaoui, Nizar; Bousfiha, Ahmed Aziz; Picard, Capucine; Barbouche, Ridha; Al-Muhsen, Saleh; Rosales, Francisco J. Espinosa; Kütükçüler, Necil; Condino Neto, Antonio; Casanova, Jean-Laurent; Bustamante, Jacinta
Source: Journal of Allergy and Clinical Immunology. Unidade: ICB
Subjects: MYCOBACTERIUM, TUBERCULOSE, INFECÇÕES BACTERIANAS E MICOSES, GRANULOMA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTI, Francesca et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. Journal of Allergy and Clinical Immunology, v. 138, n. 1, p. 214-248, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2015.11.041. Acesso em: 12 nov. 2024.
APA
Conti, F., Reyes, S. O. L., Galicia, L. B., He, J., Aksu, G., Oliveira Junior, E. B. de, et al. (2016). Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. Journal of Allergy and Clinical Immunology, 138( 1), 214-248. doi:10.1016/j.jaci.2015.11.041
NLM
Conti F, Reyes SOL, Galicia LB, He J, Aksu G, Oliveira Junior EB de, Deswarte C, Hubeau M, Karaca N, Suremain M de, Guérin A, Baba LA, Prando C, Guerrero GG, Emiroglu M, Öz FN, Nakashimada MAY, Serrano EG, Espinosa S, Barlan I, Pérez N, Regairaz L, Morales HEG, Bezrondnik L, Giovanni DD, Dbaibo G, Ailal F, Galicchio M, Oleastro M, Chemli J, Danielian S, Perez L, Ortega MC, Lavin SS, Hertecant J, Anal O, Kechout N, Al-Idrissi E, ElGhazali G, Bondareko A, Chernyshova L, Ciznar P, Herbigneaux R-M, Diabate A, Ndaga S, Konte B, Czarna A, Migaud M, Sánchez SP, Zaidi MB, Vogt G, Blanche S, Benmustapha I, Mansouri D, Abel L, Dupuis SB, Mahlaoui N, Bousfiha AA, Picard C, Barbouche R, Al-Muhsen S, Rosales FJE, Kütükçüler N, Condino Neto A, Casanova J-L, Bustamante J. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases [Internet]. Journal of Allergy and Clinical Immunology. 2016 ;138( 1): 214-248.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jaci.2015.11.041
Vancouver
Conti F, Reyes SOL, Galicia LB, He J, Aksu G, Oliveira Junior EB de, Deswarte C, Hubeau M, Karaca N, Suremain M de, Guérin A, Baba LA, Prando C, Guerrero GG, Emiroglu M, Öz FN, Nakashimada MAY, Serrano EG, Espinosa S, Barlan I, Pérez N, Regairaz L, Morales HEG, Bezrondnik L, Giovanni DD, Dbaibo G, Ailal F, Galicchio M, Oleastro M, Chemli J, Danielian S, Perez L, Ortega MC, Lavin SS, Hertecant J, Anal O, Kechout N, Al-Idrissi E, ElGhazali G, Bondareko A, Chernyshova L, Ciznar P, Herbigneaux R-M, Diabate A, Ndaga S, Konte B, Czarna A, Migaud M, Sánchez SP, Zaidi MB, Vogt G, Blanche S, Benmustapha I, Mansouri D, Abel L, Dupuis SB, Mahlaoui N, Bousfiha AA, Picard C, Barbouche R, Al-Muhsen S, Rosales FJE, Kütükçüler N, Condino Neto A, Casanova J-L, Bustamante J. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases [Internet]. Journal of Allergy and Clinical Immunology. 2016 ;138( 1): 214-248.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jaci.2015.11.041
Artigo de periodico-carta/editorial
Into action: improving access to optimum care for all primary immunodeficiency patients (2016)
Espinosa-Rosales, Francisco J. ; Condino Neto, Antonio ; Franco, José L.; Sorensen, Ricardo U.
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, INFLAMAÇÃO, DOENÇAS AUTOIMUNES, AUTOIMUNIDADE, IMUNOGENÉTICA, IMUNOGLOBULINAS, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESPINOSA-ROSALES, Francisco J. et al. Into action: improving access to optimum care for all primary immunodeficiency patients. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-016-0277-2. Acesso em: 12 nov. 2024. , 2016
APA
Espinosa-Rosales, F. J., Condino Neto, A., Franco, J. L., & Sorensen, R. U. (2016). Into action: improving access to optimum care for all primary immunodeficiency patients. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-016-0277-2
NLM
Espinosa-Rosales FJ, Condino Neto A, Franco JL, Sorensen RU. Into action: improving access to optimum care for all primary immunodeficiency patients [Internet]. Journal of Clinical Immunology. 2016 ; 36( 5): 415-417.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s10875-016-0277-2
Vancouver
Espinosa-Rosales FJ, Condino Neto A, Franco JL, Sorensen RU. Into action: improving access to optimum care for all primary immunodeficiency patients [Internet]. Journal of Clinical Immunology. 2016 ; 36( 5): 415-417.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s10875-016-0277-2

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration